Oneness Biotech Co., Ltd. (4743.TWO)
TWD 63.0
(-10.0%)
TWD 63.0
(-10.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.31 Billion TWD | -464.71% |
| 2022 | 359.97 Million TWD | 187.2% |
| 2021 | -412.82 Million TWD | -64.03% |
| 2020 | -251.67 Million TWD | 23.38% |
| 2019 | -328.46 Million TWD | -39.51% |
| 2018 | -235.43 Million TWD | -51.46% |
| 2017 | -155.44 Million TWD | -990.31% |
| 2016 | -14.25 Million TWD | 84.67% |
| 2015 | -93.01 Million TWD | -146.57% |
| 2014 | 199.72 Million TWD | -27.7% |
| 2013 | 276.25 Million TWD | 1108.59% |
| 2012 | -27.39 Million TWD | -296.26% |
| 2011 | 13.95 Million TWD | 1364.43% |
| 2010 | 953 Thousand TWD | -84.82% |
| 2009 | 6.28 Million TWD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -92.62 Million TWD | 80.95% |
| 2024 Q2 | -173.32 Million TWD | -87.14% |
| 2023 Q1 | -269.38 Million TWD | 58.57% |
| 2023 Q2 | -335.24 Million TWD | -24.45% |
| 2023 FY | -1.31 Billion TWD | -464.71% |
| 2023 Q3 | -226.62 Million TWD | 32.4% |
| 2023 Q4 | -486.31 Million TWD | -114.59% |
| 2022 Q3 | 275.64 Million TWD | -18.57% |
| 2022 Q1 | 388.53 Million TWD | 203.35% |
| 2022 FY | 359.97 Million TWD | 187.2% |
| 2022 Q4 | -650.27 Million TWD | -335.91% |
| 2022 Q2 | 338.49 Million TWD | -12.88% |
| 2021 Q2 | -472.72 Million TWD | -503.4% |
| 2021 Q3 | -175.84 Million TWD | 62.8% |
| 2021 FY | -412.82 Million TWD | -64.03% |
| 2021 Q4 | 128.08 Million TWD | 172.84% |
| 2021 Q1 | 117.18 Million TWD | 120.64% |
| 2020 Q2 | 492.37 Million TWD | 360.24% |
| 2020 FY | -251.67 Million TWD | 23.38% |
| 2020 Q4 | -567.72 Million TWD | -2606.41% |
| 2020 Q1 | -189.19 Million TWD | -9.67% |
| 2020 Q3 | 22.65 Million TWD | -95.4% |
| 2019 Q2 | -63.54 Million TWD | -107.97% |
| 2019 Q1 | -30.55 Million TWD | 38.58% |
| 2019 Q4 | -172.5 Million TWD | -210.31% |
| 2019 FY | -328.46 Million TWD | -39.51% |
| 2019 Q3 | -55.59 Million TWD | 12.52% |
| 2018 Q4 | -49.75 Million TWD | 55.12% |
| 2018 Q1 | -56.55 Million TWD | -28.47% |
| 2018 Q2 | -18.27 Million TWD | 67.69% |
| 2018 Q3 | -110.85 Million TWD | -506.69% |
| 2018 FY | -235.43 Million TWD | -51.46% |
| 2017 Q2 | -38.1 Million TWD | 6.32% |
| 2017 FY | -155.44 Million TWD | -990.31% |
| 2017 Q4 | -44.02 Million TWD | -34.86% |
| 2017 Q3 | -32.64 Million TWD | 14.33% |
| 2017 Q1 | -40.67 Million TWD | -8.77% |
| 2016 Q4 | -37.39 Million TWD | -145.24% |
| 2016 Q3 | 82.66 Million TWD | 427.61% |
| 2016 Q2 | -25.23 Million TWD | 26.42% |
| 2016 Q1 | -34.29 Million TWD | -23.02% |
| 2016 FY | -14.25 Million TWD | 84.67% |
| 2015 Q3 | -18.6 Million TWD | 17.61% |
| 2015 Q2 | -22.58 Million TWD | 5.72% |
| 2015 Q1 | -23.95 Million TWD | -162.22% |
| 2015 FY | -93.01 Million TWD | -146.57% |
| 2015 Q4 | -27.87 Million TWD | -49.83% |
| 2014 Q4 | 38.49 Million TWD | -78.57% |
| 2014 FY | 199.72 Million TWD | -27.7% |
| 2014 Q3 | 179.65 Million TWD | 21835.65% |
| 2014 Q2 | 819 Thousand TWD | 104.26% |
| 2014 Q1 | -19.23 Million TWD | 55.46% |
| 2013 Q3 | 177.77 Million TWD | 46.83% |
| 2013 Q4 | -43.19 Million TWD | -124.3% |
| 2013 FY | 276.25 Million TWD | 1108.59% |
| 2013 Q2 | 121.08 Million TWD | 488.05% |
| 2013 Q1 | 20.59 Million TWD | 109.67% |
| 2012 Q3 | -40.71 Million TWD | -10.74% |
| 2012 Q4 | 9.82 Million TWD | 124.12% |
| 2012 Q1 | 40.35 Million TWD | 410.91% |
| 2012 FY | -27.39 Million TWD | -296.26% |
| 2012 Q2 | -36.76 Million TWD | -191.11% |
| 2011 FY | 13.95 Million TWD | 1364.43% |
| 2011 Q1 | -16.69 Million TWD | -219.55% |
| 2011 Q2 | 27.25 Million TWD | 263.24% |
| 2011 Q3 | -4.5 Million TWD | -116.52% |
| 2011 Q4 | 7.89 Million TWD | 275.46% |
| 2010 Q2 | -14.08 Million TWD | -282.75% |
| 2010 FY | 953 Thousand TWD | -84.82% |
| 2010 Q4 | 13.96 Million TWD | 310.41% |
| 2010 Q1 | 7.7 Million TWD | 0.0% |
| 2010 Q3 | -6.63 Million TWD | 52.86% |
| 2009 FY | 6.28 Million TWD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -51.78 Million TWD | -2435.373% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 251.01 Million TWD | 623.027% |
| Level Biotechnology Inc. | 62.9 Million TWD | 2187.063% |
| Sagittarius Life Science Corp | -55.03 Million TWD | -2285.339% |
| NeoCore Technology Co., Ltd. | -64.64 Million TWD | -1930.887% |
| TaiMed Biologics Inc. | -194.81 Million TWD | -573.922% |
| GlycoNex Incorporation | -178.36 Million TWD | -636.069% |
| VBI | -6.6 Million TWD | -19788.911% |
| GeneReach Biotechnology Corp. | -166.27 Million TWD | -689.599% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -10.68 Million TWD | -12190.461% |
| SynCore Biotechnology Co.,Ltd | -38.17 Million TWD | -3339.346% |
| Genomics BioSci & Tech. Co.,Ltd. | -168.06 Million TWD | -681.162% |
| Visgeneer Inc. | -19.58 Million TWD | -6602.062% |
| Mycenax Biotech Inc. | -682.84 Million TWD | -92.264% |
| Sunmax Biotechnology Co., Ltd. | 625.7 Million TWD | 309.821% |
| G&E Herbal Biotechnology Co., Ltd. | 72.4 Million TWD | 1913.352% |
| Neith Corporation | -40.03 Million TWD | -3179.462% |
| Medigen Vaccine Biologics Corporation | -1.15 Billion TWD | -13.194% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.04 Million TWD | -21611.047% |
| Enimmune corporation | -223.74 Million TWD | -486.775% |
| TaiRx, Inc. | -212.29 Million TWD | -518.425% |
| CHO Pharma, Inc. | -306.08 Million TWD | -328.92% |
| EirGenix Inc. | -915.2 Million TWD | -43.45% |
| BioLASCO Taiwan Co., Ltd. | 49.74 Million TWD | 2739.3% |
| Sunny Pharmtech Inc. | -63.32 Million TWD | -1973.384% |
| Lin BioScience, Inc. | -687.19 Million TWD | -91.049% |
| BioGend Therapeutics Co., Ltd. | -156.32 Million TWD | -739.832% |
| Feng Chi Biotech Corp. | 22.79 Million TWD | 5860.21% |
| Bio Preventive Medicine Corp. | -73.28 Million TWD | -1691.454% |
| Lukas Biomedical Inc. | -47.35 Million TWD | -2672.511% |
| RBC Bioscience Corporation | 6.43 Million TWD | 20517.838% |
| BiOptic Inc. | 37.74 Million TWD | 3578.07% |
| BRIM Biotechnology, Inc. | -688.02 Million TWD | -90.818% |
| Shine-On BioMedical Co.,Ltd. | -37.16 Million TWD | -3432.536% |
| Great Novel Therapeutics Biotech & Medicals | -61.54 Million TWD | -2033.356% |
| Syngen Biotech Co.,Ltd. | 274.82 Million TWD | 577.707% |
| Advagene Biopharma Co., Ltd. | -92.11 Million TWD | -1325.325% |
| NaviFUS Corp. | -65.72 Million TWD | -1897.394% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -88.08 Million TWD | -1390.387% |
| Sinew Pharma Inc. | -170.92 Million TWD | -668.113% |
| Andros Pharmaceuticals Co.,Ltd | -68.15 Million TWD | -1826.183% |
| Greenyn Biotechnology Co., Ltd | 130.66 Million TWD | 1104.766% |
| Lumosa Therapeutics Co., Ltd. | -238.04 Million TWD | -451.53% |
| AP Biosciences Inc | -339.29 Million TWD | -286.94% |
| Medigen Biotechnology Corp. | -561.29 Million TWD | -133.899% |
| 3D Global Biotech Inc. | -57.95 Million TWD | -2165.478% |
| Pharmosa Biopharm Inc. | 8.45 Million TWD | 15625.863% |
| Intech Biopharm Corporation | -337.98 Million TWD | -288.437% |
| Eusol Biotech Co.,Ltd. | -51.61 Million TWD | -2443.675% |
| TWi Biotechnology, Inc. | -170.68 Million TWD | -669.184% |
| Ever Supreme Bio Technology Co., Ltd | 539.39 Million TWD | 343.395% |
| TCI GENE Inc. | 11.67 Million TWD | 11347.04% |
| MegaPro Biomedical Co., Ltd | -127.54 Million TWD | -929.312% |
| Senhwa Biosciences, Inc. | -296.3 Million TWD | -343.078% |
| Taiwan Bio Therapeutics Co., Ltd | -217.51 Million TWD | -503.584% |
| NatureWise Biotech & Medicals Corporation | 10.12 Million TWD | 13072.994% |
| PharmaEngine, Inc. | 274.65 Million TWD | 578.015% |
| Savior Lifetec Corporation | 30.03 Million TWD | 4471.851% |
| TaiGen Biopharmaceuticals Holdings Limited | 136.73 Million TWD | 1060.182% |
| OBI Pharma, Inc. | -1.04 Billion TWD | -25.456% |
| Meribank Biotech Co., Ltd | -125.34 Million TWD | -947.394% |
| Acepodia, Inc. | -817.31 Million TWD | -60.631% |
| Caliway Biopharmaceuticals Co., Ltd. | -488.45 Million TWD | -168.78% |